Temsirolimus-resistant, checkpoint-deficient, homeostatic cytokine-responsive autologous TH1/TC1 cells for therapy of relapsed, refractory multiple myeloma (RRMM)

Temsirolimus-resistant, checkpoint-deficient, homeostatic cytokine-responsive autologous TH1/TC1 cells for therapy of relapsed, refractory multiple myeloma (RRMM)

Saved in:
Bibliographic Details
Published in:Cytotherapy (Oxford, England) Vol. 23; no. 5; p. S86
Main Authors: Felizardo, T., Mosquera Limas, S., Zhu, N., Bushera, H., Glass, D., Hari, P., Dhakal, B., Fowler, D.H.
Format: Journal Article
Language:English
Published: Elsevier Inc 01-05-2021
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1465-3249
1477-2566
DOI:10.1016/S1465324921004011